Skip to main content

John Wollobin

Analyst

Citizens

Equibles does not estimate personal net worth.

About John Wollobin

John Wollobin is recorded as Analyst at Citizens. John Wollobin has spoken on 3 earnings calls and 1 other investor event across 3 companies, most recently for DBV Technologies S.A. on October 28, 2026. Those appearances were for DBV Technologies S.A. (DBVT), Rhythm Pharmaceuticals, Inc. (RYTM) and Crinetics Pharmaceuticals, Inc.. The companies whose calls John Wollobin spoke on are classified in the Healthcare sector.

John Wollobin on recent calls

“I might have missed this, but can you discuss what the warning letter details included and what remediation activities are still ongoing? And then any thoughts on getting a second manufacturer to have redundant supply?”
Analyst — Citizens, DBV Technologies S.A. Q3 FY2026 Earnings Call ·
“A couple from me, I might have missed this, Jen, but I think last update you said time to pay drug was about 60 to 90 days, and I was wondering if there was an update there.”
Analyst — Citizens, Rhythm Pharmaceuticals Q2 2026 Earnings Conference Call ·
“Just wondering, without knowing the true context or size of these changes, any chance that this could get pushed to 4Q, or is this going to be relatively easy to maneuver through?”
H.C. Wainwright BioConnect Conference ·
“Just for one from me on Palisanofi, when we think about the unique prescriber base, do you have a sense of how many agro-mediculity patients those prescribers have under their just looking for some commentary about kind of the deepening of the prescribers as well as the broadening over time.”
Analyst — Citizens, Crinetics Pharmaceuticals, Inc. Q1 FY2026 Earnings Call ·

Affiliation history

  • Citizens

    Analyst

    Transcript header (unverified)

    Current

Company network

Crinetics Pharmaceuticals, Inc.

Biotechnology · Healthcare

1 appearance Latest appearance 2026-05-07

Recent activity